Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
English-speaking
Age \>/= 18 years old
Survivors with a primary diagnosis of stage I-III breast, ovarian uterine, or endometrial cancer
Moderate to severe chemotherapy induced peripheral neuropathy, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale
Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
If taking anti-neuropathy medications, they are on a stable regiment (no change in 3 months)
ECOG performance status 0-2
English speaking
Age \>/= 18 years old
Survivors with a primary diagnosis of Stage I-III breast, ovarian, uterine, or endometrial cancer
CIPN symptoms such as numbness, tingling, or pain ratings \< 2 on a 0-10 NRS scale
Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
ECOG performance status 0-2
You may not be if
Participants with metastatic disease
Participants who are currently receiving physical therapy or practicing yoga for any reason
Patients with metastatic disease
Patients taking anti-neuropathy medication
Patients who are currently receiving physical therapy or practicing yoga for any reason
Clareo Health | Yoga for Symptoms of Nerve Damage Caused by Chemotherapy
